Skip to main content

Praxis Precision Medicines, Inc.

corporate_fare Company Profile

Praxis Precision Medicines, Inc.

PRAX·NASDAQ·Life Sciences·CIK 0001689548

We are a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company. We translate insights from genetic epilepsies to develop therapies for CNS disorders marked by an imbalance in neuronal excitation and inhibition. Normal brain function relies on a delicate balance of excitation and inhibition in neuronal circuits, and dysregulation can lead to abnormal function and neurological disorders. We apply genetic insights to discover and develop therapies for neurological disorders using two proprietary platforms, based on our understanding of shared biological targets and circuits in the brain. Each platform currently has multiple programs with potential for expansion. Our Cerebrum™ platform, for small molecules, uses a deep understanding of neuronal excitability and networks, applying computational and experimental tools to develop orally available precision therapies. Our Solidus™ platform, for antisense oligonucleotides (ASO), is an efficient, targeted precision medicine discovery and development engine built on a proprietary computational methodology. Both platforms use a patient-guided approach, leveraging translational tools like novel transgenic and predictive translational animal models and electrophysiology markers, to achieve proof-of-concept in patients efficiently. This approach has resulted in a diversified, multimodal CNS portfolio with four clinical-stage product candidates for movement disorders and epilepsy. Cerebrum™ uses computational and experimental tools to discover and develop CNS small molecule therapies. Our ion channel discovery science team and collaborators create and execute novel screening cascades for selected genetic targets. Our multiscale disease models link genetic causes to network function to identify disease drivers. We use translational biomarkers like quantitative electroencephalography (qEEG) to guide dose selection. Genomics and informatics guide the precision application of our candidates to identify, stratify, and activate patients for trial recruitment and execution.

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 23 items for PRAX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for PRAX spans 8-K, 10-Q, 10-K.

Recent high-impact activity:

  • Praxis Sets $20B+ Peak Sales Target, Discloses Launch Pricing and Two PDUFA Dates
  • Praxis Posts Q3 Loss of $94.2M; Two FDA Decisions Due by Late January 2027
  • Praxis Posts $94.2M Q3 Loss, $1.3B Cash Ahead of Two FDA Decisions
  • Praxis Precision Medicines Extends Cash Runway into 2028, Reports Q2 Financials
  • Praxis Q2: $1.4B Cash, Two PDUFAs on Track, No FDA Red Flags

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$0
Net Income
-$303.27M
Diluted EPS
-$13.48
Op. Cash Flow
-$249.07M
Free Cash Flow
-$249.12M
Operating Income
-$326.2M
Cash & Equivalents
$357.33M
Debt / Equity
0.00×
Shares Outstanding
25.2M sh
Source: 10-K · filed 2026-02-19 · accession 0001689548-26-000029

Short Interest & Short Volume

8.69 days to cover

FINRA reported short interest of 4,207,692 shares in PRAX as of the October 30, 2026 settlement, a 7.3% increase from the prior period — about 8.7 days to cover at its recent average daily volume. On November 20, 2026, 66.5% of PRAX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)4,207,692 shares as of October 30, 2026
Change vs prior period▲ 7.3%
Days to cover8.69 at avg daily volume of 484,385
Daily short volume (FINRA facilities)66.5% of 375,722 shares on November 20, 2026
5-day average short volume49.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with P →
$275 -8.46% today
52-week range · as of 2026-11-12 $160.11 – $392.7
Market cap
$8.4B
Volume
806.2K (1.5× avg)
3-mo avg 541.2K
Live data · 2026-11-22 12:38 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed PRAX - Latest Insights

PRAX
Nov 12, 2026, 5:01 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $324.76
Real-time Price: $275.00 info
Change: -$49.76 (-15%) info
Market Cap: $8.397B info
PRAX
Nov 09, 2026, 7:02 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $270.00
Real-time Price: $275.00 info
Change: +$5.00 (+2%) info
Market Cap: $8.397B info
PRAX
Nov 09, 2026, 7:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $270.00
Real-time Price: $275.00 info
Change: +$5.00 (+2%) info
Market Cap: $8.397B info
PRAX
Aug 06, 2026, 8:32 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $337.00
Real-time Price: $275.00 info
Change: -$62.00 (-18%) info
Market Cap: $8.397B info
PRAX
Aug 06, 2026, 8:31 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $337.10
Real-time Price: $275.00 info
Change: -$62.10 (-18%) info
Market Cap: $8.397B info
PRAX
Jul 07, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $330.00
Real-time Price: $275.00 info
Change: -$55.00 (-17%) info
Market Cap: $8.397B info
PRAX
Jun 29, 2026, 4:40 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $334.00
Real-time Price: $275.00 info
Change: -$59.00 (-18%) info
Market Cap: $8.397B info
PRAX
Jun 29, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $340.00
Real-time Price: $275.00 info
Change: -$65.00 (-19%) info
Market Cap: $8.397B info
PRAX
Jun 22, 2026, 4:43 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $303.39
Real-time Price: $275.00 info
Change: -$28.39 (-9%) info
Market Cap: $8.397B info
PRAX
Jun 22, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $282.31
Real-time Price: $275.00 info
Change: -$7.31 (-3%) info
Market Cap: $8.397B info
PRAX
Jun 01, 2026, 4:33 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $335.16
Real-time Price: $275.00 info
Change: -$60.16 (-18%) info
Market Cap: $8.397B info
PRAX
Jun 01, 2026, 4:28 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $285.00
Real-time Price: $275.00 info
Change: -$10.00 (-4%) info
Market Cap: $8.397B info
PRAX
May 07, 2026, 9:11 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $339.00
Real-time Price: $275.00 info
Change: -$64.00 (-19%) info
Market Cap: $8.397B info
PRAX
May 07, 2026, 9:06 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $339.00
Real-time Price: $275.00 info
Change: -$64.00 (-19%) info
Market Cap: $8.397B info
PRAX
Apr 14, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $350.00
Real-time Price: $275.00 info
Change: -$75.00 (-21%) info
Market Cap: $8.397B info
PRAX
Apr 06, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $310.38
Real-time Price: $275.00 info
Change: -$35.38 (-11%) info
Market Cap: $8.397B info
PRAX
Mar 30, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $279.00
Real-time Price: $275.00 info
Change: -$4.00 (-1%) info
Market Cap: $8.397B info
PRAX
Feb 19, 2026, 8:02 AM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $328.93
Real-time Price: $275.00 info
Change: -$53.93 (-16%) info
Market Cap: $8.397B info
PRAX
Feb 19, 2026, 8:01 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $328.93
Real-time Price: $275.00 info
Change: -$53.93 (-16%) info
Market Cap: $8.397B info
PRAX
Jan 08, 2026, 4:49 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $295.10
Real-time Price: $275.00 info
Change: -$20.10 (-7%) info
Market Cap: $8.397B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets